ANXA2 and pachyonychia congenita: The results confirmed that LINC00941 dramatically promoted ANXA2 expression as well as inducing increased p-FAK and p-AKT, implying that LINC00941 might promote PC progression via activating the FAK/AKT signaling axis (Fig. 6C, D).